Annual Net Income
-$15.73 M
+$11.60 M+42.43%
31 December 2023
Summary:
Aileron Therapeutics annual net profit is currently -$15.73 million, with the most recent change of +$11.60 million (+42.43%) on 31 December 2023. During the last 3 years, it has risen by +$5.42 million (+25.64%). ALRN annual net income is now -22.16% below its all-time high of -$12.88 million, reached on 31 December 2015.ALRN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.85 M
+$3.10 M+34.61%
30 September 2024
Summary:
Aileron Therapeutics quarterly net profit is currently -$5.85 million, with the most recent change of +$3.10 million (+34.61%) on 30 September 2024. Over the past year, it has dropped by -$4.02 million (-220.03%). ALRN quarterly net income is now -227.20% below its all-time high of -$1.79 million, reached on 30 June 2023.ALRN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$29.24 M
-$4.02 M-15.94%
30 September 2024
Summary:
Aileron Therapeutics TTM net profit is currently -$29.24 million, with the most recent change of -$4.02 million (-15.94%) on 30 September 2024. Over the past year, it has dropped by -$16.30 million (-125.97%). ALRN TTM net income is now -644.99% below its all-time high of -$3.92 million, reached on 31 March 2016.ALRN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALRN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +42.4% | -220.0% | -126.0% |
| 3 y3 years | +25.6% | +12.8% | -20.0% |
| 5 y5 years | +50.1% | +24.6% | -0.3% |
ALRN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +42.4% | -227.2% | +34.6% | -126.0% | +2.3% |
| 5 y | 5 years | at high | +50.1% | -227.2% | +34.6% | -126.0% | +2.3% |
| alltime | all time | -22.2% | +50.1% | -227.2% | +38.4% | -645.0% | +7.3% |
Aileron Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.85 M(-34.6%) | -$29.24 M(+15.9%) |
| June 2024 | - | -$8.94 M(+25.7%) | -$25.22 M(+39.6%) |
| Mar 2024 | - | -$7.11 M(-3.1%) | -$18.07 M(+14.8%) |
| Dec 2023 | -$15.73 M(-42.4%) | -$7.34 M(+301.7%) | -$15.73 M(+21.6%) |
| Sept 2023 | - | -$1.83 M(+2.2%) | -$12.94 M(-26.0%) |
| June 2023 | - | -$1.79 M(-62.6%) | -$17.48 M(-26.2%) |
| Mar 2023 | - | -$4.78 M(+5.1%) | -$23.69 M(-13.3%) |
| Dec 2022 | -$27.33 M(+4.5%) | -$4.55 M(-28.6%) | -$27.33 M(-7.6%) |
| Sept 2022 | - | -$6.37 M(-20.3%) | -$29.58 M(-1.1%) |
| June 2022 | - | -$7.99 M(-5.1%) | -$29.92 M(+8.4%) |
| Mar 2022 | - | -$8.42 M(+23.9%) | -$27.61 M(+5.5%) |
| Dec 2021 | -$26.16 M(+23.7%) | -$6.80 M(+1.4%) | -$26.16 M(+7.4%) |
| Sept 2021 | - | -$6.70 M(+17.9%) | -$24.36 M(+7.4%) |
| June 2021 | - | -$5.69 M(-18.5%) | -$22.68 M(+6.1%) |
| Mar 2021 | - | -$6.97 M(+39.6%) | -$21.38 M(+1.1%) |
| Dec 2020 | -$21.16 M | -$5.00 M(-0.5%) | -$21.16 M(-9.6%) |
| Sept 2020 | - | -$5.02 M(+14.4%) | -$23.40 M(-10.4%) |
| June 2020 | - | -$4.39 M(-34.9%) | -$26.12 M(-9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$6.75 M(-6.7%) | -$28.90 M(-1.6%) |
| Dec 2019 | -$29.37 M(-6.9%) | -$7.24 M(-6.6%) | -$29.37 M(+0.7%) |
| Sept 2019 | - | -$7.75 M(+8.0%) | -$29.17 M(+1.1%) |
| June 2019 | - | -$7.17 M(-0.6%) | -$28.85 M(-7.4%) |
| Mar 2019 | - | -$7.21 M(+2.5%) | -$31.17 M(-1.2%) |
| Dec 2018 | -$31.55 M(+39.6%) | -$7.03 M(-5.4%) | -$31.55 M(+0.5%) |
| Sept 2018 | - | -$7.43 M(-21.7%) | -$31.38 M(+3.9%) |
| June 2018 | - | -$9.49 M(+25.1%) | -$30.20 M(+17.8%) |
| Mar 2018 | - | -$7.59 M(+10.5%) | -$25.64 M(+13.4%) |
| Dec 2017 | -$22.60 M(+24.7%) | -$6.87 M(+9.7%) | -$22.60 M(+12.0%) |
| Sept 2017 | - | -$6.26 M(+27.1%) | -$20.18 M(+11.2%) |
| June 2017 | - | -$4.92 M(+8.0%) | -$18.14 M(-3.3%) |
| Mar 2017 | - | -$4.56 M(+2.6%) | -$18.75 M(+3.5%) |
| Dec 2016 | -$18.12 M(+40.7%) | -$4.44 M(+5.2%) | -$18.12 M(+32.5%) |
| Sept 2016 | - | -$4.22 M(-23.7%) | -$13.68 M(+44.6%) |
| June 2016 | - | -$5.53 M(+41.0%) | -$9.46 M(+141.0%) |
| Mar 2016 | - | -$3.92 M | -$3.92 M |
| Dec 2015 | -$12.88 M | - | - |
FAQ
- What is Aileron Therapeutics annual net profit?
- What is the all time high annual net income for Aileron Therapeutics?
- What is Aileron Therapeutics annual net income year-on-year change?
- What is Aileron Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Aileron Therapeutics?
- What is Aileron Therapeutics quarterly net income year-on-year change?
- What is Aileron Therapeutics TTM net profit?
- What is the all time high TTM net income for Aileron Therapeutics?
- What is Aileron Therapeutics TTM net income year-on-year change?
What is Aileron Therapeutics annual net profit?
The current annual net income of ALRN is -$15.73 M
What is the all time high annual net income for Aileron Therapeutics?
Aileron Therapeutics all-time high annual net profit is -$12.88 M
What is Aileron Therapeutics annual net income year-on-year change?
Over the past year, ALRN annual net profit has changed by +$11.60 M (+42.43%)
What is Aileron Therapeutics quarterly net profit?
The current quarterly net income of ALRN is -$5.85 M
What is the all time high quarterly net income for Aileron Therapeutics?
Aileron Therapeutics all-time high quarterly net profit is -$1.79 M
What is Aileron Therapeutics quarterly net income year-on-year change?
Over the past year, ALRN quarterly net profit has changed by -$4.02 M (-220.03%)
What is Aileron Therapeutics TTM net profit?
The current TTM net income of ALRN is -$29.24 M
What is the all time high TTM net income for Aileron Therapeutics?
Aileron Therapeutics all-time high TTM net profit is -$3.92 M
What is Aileron Therapeutics TTM net income year-on-year change?
Over the past year, ALRN TTM net profit has changed by -$16.30 M (-125.97%)